Matches in Nanopublications for { ?s ?p "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP318807.RAf9hkcgvq3WJK3zwIZiBaHhZIgrlTVsKgb6NBsnikk5A130_assertion description "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318807.RAf9hkcgvq3WJK3zwIZiBaHhZIgrlTVsKgb6NBsnikk5A130_provenance.
- NP679005.RAesp1_g5HJqwy16RnMw3928W-dtb90VaBzErPNZqf544130_assertion description "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679005.RAesp1_g5HJqwy16RnMw3928W-dtb90VaBzErPNZqf544130_provenance.
- NP679385.RAdkSnyMp7mP9eiiU9X9ZH0iBdGh54PACdwN7Xx6VKAeI130_assertion description "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP679385.RAdkSnyMp7mP9eiiU9X9ZH0iBdGh54PACdwN7Xx6VKAeI130_provenance.
- assertion description "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP756685.RAWdpdMGzDzi0BQzoE2qfG5R0W8tXneIM2EDGxW_21ZL8130_assertion description "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756685.RAWdpdMGzDzi0BQzoE2qfG5R0W8tXneIM2EDGxW_21ZL8130_provenance.
- NP756690.RAWFLOcrsKN2FenvxucScCPe_g_x3IkQD0Ub7LhXL89Z4130_assertion description "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756690.RAWFLOcrsKN2FenvxucScCPe_g_x3IkQD0Ub7LhXL89Z4130_provenance.
- NP756686.RAHWck2dfhMpSlZ_nmnKnDJG-N4eCdBLoYmrur3vR6dJU130_assertion description "[We identified S100A8 and S100A9 as novel NF-kappaB target genes in HCC cells during inflammation-associated liver carcinogenesis and provide experimental evidence that increased co-expression of both proteins supports malignant progression by activation of ROS-dependent signaling pathways and protection from cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756686.RAHWck2dfhMpSlZ_nmnKnDJG-N4eCdBLoYmrur3vR6dJU130_provenance.